These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2290622)

  • 1. Competitive substrate inhibition in the histochemistry of cholinesterase activity in Alzheimer's disease.
    Schätz CR; Geula C; Mesulam M
    Neurosci Lett; 1990 Sep; 117(1-2):56-61. PubMed ID: 2290622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability.
    Wright CI; Geula C; Mesulam MM
    Ann Neurol; 1993 Sep; 34(3):373-84. PubMed ID: 8363355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Special properties of cholinesterases in the cerebral cortex of Alzheimer's disease.
    Geula C; Mesulam M
    Brain Res; 1989 Sep; 498(1):185-9. PubMed ID: 2790472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rivastigmine is a potent inhibitor of acetyl- and butyrylcholinesterase in Alzheimer's plaques and tangles.
    Eskander MF; Nagykery NG; Leung EY; Khelghati B; Geula C
    Brain Res; 2005 Oct; 1060(1-2):144-52. PubMed ID: 16212945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anatomy of cholinesterase inhibition in Alzheimer's disease: effect of physostigmine and tetrahydroaminoacridine on plaques and tangles.
    Mesulam MM; Geula C; Morán MA
    Ann Neurol; 1987 Dec; 22(6):683-91. PubMed ID: 3435078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protease inhibitors and indolamines selectively inhibit cholinesterases in the histopathologic structures of Alzheimer's disease.
    Wright CI; Geula C; Mesulam MM
    Ann N Y Acad Sci; 1993 Sep; 695():65-8. PubMed ID: 8239315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylcholinesterase and its association with heparan sulphate proteoglycans in cortical amyloid deposits of Alzheimer's disease.
    Kalaria RN; Kroon SN; Grahovac I; Perry G
    Neuroscience; 1992 Nov; 51(1):177-84. PubMed ID: 1465181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and Preliminary Evaluation of Phenyl 4-123I-Iodophenylcarbamate for Visualization of Cholinesterases Associated with Alzheimer Disease Pathology.
    Macdonald IR; Reid GA; Pottie IR; Martin E; Darvesh S
    J Nucl Med; 2016 Feb; 57(2):297-302. PubMed ID: 26541777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential laminar distribution of acetylcholinesterase and butyrylcholinesterase containing tangles in the cerebral cortex of Alzheimer's disease.
    Coleman AE; Geula C; Price BH; Mesulam MM
    Brain Res; 1992 Nov; 596(1-2):340-4. PubMed ID: 1467998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical differentiation of cholinesterases from normal and Alzheimer's disease cortex.
    Ciro A; Park J; Burkhard G; Yan N; Geula C
    Curr Alzheimer Res; 2012 Jan; 9(1):138-43. PubMed ID: 21244353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and histochemical comparison of cholinesterases in normal and Alzheimer brain tissues.
    Darvesh S; Reid GA; Martin E
    Curr Alzheimer Res; 2010 Aug; 7(5):386-400. PubMed ID: 19939227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinesterase activity in the plaques, tangles and angiopathy of Alzheimer's disease does not emanate from amyloid.
    Geula C; Greenberg BD; Mesulam MM
    Brain Res; 1994 May; 644(2):327-30. PubMed ID: 8050043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current concepts on selected plant secondary metabolites with promising inhibitory effects against enzymes linked to Alzheimer's disease.
    Orhan IE
    Curr Med Chem; 2012; 19(14):2252-61. PubMed ID: 22414107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electron microscopic localization of cholinesterase activity in Alzheimer brain tissue.
    Carson KA; Geula C; Mesulam MM
    Brain Res; 1991 Feb; 540(1-2):204-8. PubMed ID: 2054612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase.
    Pacheco G; Palacios-Esquivel R; Moss DE
    J Pharmacol Exp Ther; 1995 Aug; 274(2):767-70. PubMed ID: 7636741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrastructural localization of acetylcholinesterase in neurofibrillary tangles, neuropil threads and senile plaques in aged and Alzheimer's brain.
    Gomez-Ramos P; Mufson EJ; Moran MA
    Brain Res; 1992 Jan; 569(2):229-37. PubMed ID: 1540829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibitors of butyrylcholinesterase: a valid alternative for therapy of Alzheimer's disease?
    Giacobini E
    Drugs Aging; 2001; 18(12):891-8. PubMed ID: 11888344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease inhibitors and indoleamines selectively inhibit cholinesterases in the histopathologic structures of Alzheimer disease.
    Wright CI; Guela C; Mesulam MM
    Proc Natl Acad Sci U S A; 1993 Jan; 90(2):683-6. PubMed ID: 8421706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empirical evidence of neuroprotection by dual cholinesterase inhibition in Alzheimer's disease.
    Venneri A; McGeown WJ; Shanks MF
    Neuroreport; 2005 Feb; 16(2):107-10. PubMed ID: 15671856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Widely spread butyrylcholinesterase can hydrolyze acetylcholine in the normal and Alzheimer brain.
    Mesulam M; Guillozet A; Shaw P; Quinn B
    Neurobiol Dis; 2002 Feb; 9(1):88-93. PubMed ID: 11848688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.